SPECT/CT imaging in children with papillary thyroid carcinoma

Pediatric Radiology

Volumn 41, Issue 8, 2011, Pages 1008-1012

  Kim, Hwa Young ^a   Gelfand, Michael J ^a   Sharp, Susan E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Neck imaging; Pediatrics; Radioactive iodine; SPECT CT; Thyroid cancer

Indexed keywords

IODINE 123; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; CANCER LOCALIZATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROGLOSSAL DUCT CYST; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052610608     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-011-2039-x     Document Type: Article

References (18)

1. A Bockisch LS Freudenberg D Schmidt, et al. 2009 Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging Semin Nucl Med 39 276 289 19497404 10.1053/j.semnuclmed.2009.03.003
2. N Aide N Heutte JP Rame, et al. 2009 Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer J Clin Endocrinol Metab 94 2075 2084 19276233 10.1210/jc.2008-2313 1:CAS:528:DC%2BD1MXntFGmt7s%3D
3. K Tharp O Israel J Hausmann, et al. 2004 Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 1435 1442 15221294 10.1007/s00259-004- 1565-2 1:STN:280:DC%2BD2cvnvFeltQ%3D%3D (Pubitemid 39361941)
4. KK Wong N Zarzhevsky JM Cahill, et al. 2008 Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma AJR 191 1785 1794 19020251 10.2214/AJR.08.1218
5. H Wang HL Fu JN Li, et al. 2009 The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer Clin Imaging 33 49 54 19135930 10.1016/j.clinimag.2008.06.024 1:CAS:528:DC%2BD1MXnvVaqt7w%3D
6. L Chen Q Luo Y Shen, et al. 2008 Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma J Nucl Med 49 1952 1957 18997044 10.2967/jnumed.108.052399
7. S Kohlfuerst I Igerc M Lobnig, et al. 2009 Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen Eur J Nucl Med Mol Imaging 36 886 893 19169681 10.1007/s00259-008-1044-2 1:STN:280:DC%2BD1MzjtVaqsA%3D%3D
8. D Schmidt A Szikszai R Linke, et al. 2009 Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation J Nucl Med 50 18 23 19091884 10.2967/jnumed.108.052746
9. ImPACT. London, UK. www.impactscan.org
10. CS O'Gorman J Hamilton M Rachmiel, et al. 2010 Thyroid cancer in childhood: a retrospective review of childhood course Thyroid 20 375 380 20373982 10.1089/thy.2009.0386
11. SW Lee J Lee HJ Lee, et al. 2007 Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer Thyroid 17 341 346 17465864 10.1089/thy.2006.0274 (Pubitemid 46776138)
12. JC Sisson YK Dewaraja EJ Wizauer, et al. 2009 Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine Thyroid 19 297 303 19207003 10.1089/thy.2008.0426 1:CAS:528:DC%2BD1MXivVGktbg%3D
13. LS Freudenberg C Fromke T Petrich, et al. 2010 Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer Exp Clin Endocrinol Diabetes 118 393 399 19856257 10.1055/s-0029-1225350 1:CAS:528:DC%2BC3cXhtVeisL%2FM
14. LS Freudenberg W Jentzen RJ Marlowe, et al. 2007 124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer Exp Clin Endocrinol Diabetes 115 690 693 18058605 10.1055/s-2007-985360 1:CAS:528:DC%2BD1cXitFaisbs%3D (Pubitemid 350220410)
15. KS Kolbert KS Pentlow JR Pearson, et al. 2007 Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software J Nucl Med 48 143 149 17204711 1:CAS:528:DC%2BD2sXhvFKmtro%3D (Pubitemid 47555388)
16. LS Freudenberg A Frilling H Kuhl, et al. 2007 Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer Eur Radiol 17 3139 3147 18004607 10.1007/s00330-007-0682-2 (Pubitemid 350147679)
17. G Saab AA Driedger W Pavlosky, et al. 2006 Thyroid-stimulating hormone-stimulated fused positron emission tomography/computed tomography in the evaluation of recurrence in 131I-negative papillary thyroid carcinoma Thyroid 16 267 272 16571089 10.1089/thy.2006.16.267 1:CAS:528:DC%2BD28XivFOmtbk%3D
18. KK Wong N Zarzhevsky JM Cahill, et al. 2009 Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma Br J Radiol 82 860 876 19433487 10.1259/bjr/25645894 1:STN:280:DC%2BD1MnislCntw%3D%3D